| Name | Title | Contact Details |
|---|
Thrasys, Inc. delivers a new generation of information technology for health plans, healthcare providers, and community-based organizations to create integrated clinical and community-based networks to coordinate services and manage health for indivi
ACT-Point of Sale Point of Sale systems for Restaurant and Retail, ACT-Point of Sale Point of Sale Windows systems and Apple Software Systems, ACT Digital Display, Point of Sale Hardware and Software offering Leasing options and full installation and s...
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Business World is a Westlake Village, CA-based company in the Software and Internet sector.
Conga delivers the worlds most scalable revenue lifecycle management solution. Crush complexity. Deliver Certainty.